SCHEMBL19741637

SCHEMBL19741637

CC(C)CC(NCc1cc(C(=O)O)ccn1)C1CCCO1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KDM4C Q9H3R0 2/20 0.40
▸ HPGD P15428 1/20 0.39
▸ KDM5B Q9UGL1 4/20 0.39
▸ KDM5C P41229 2/20 0.37
▸ KDM6B O15054 1/20 0.37
▸ KDM4A O75164 1/20 0.37
▸ KDM5A P29375 1/20 0.37
▸ KDM2B Q8NHM5 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ HCAR3 P49019 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ HTT P42858 2/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ SLC6A3 Q01959 2/20 0.35
▸ LMNA P02545 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19741636 1.00 KDM4C (0.40) KDM4CHPGDKDM5BKDM5CKDM6B
SCHEMBL17144518 0.73 TRPV3 (0.50) KDM4CKDM5BKDM5CKDM6BKDM4A
SCHEMBL17144520 0.73 TRPV3 (0.50) KDM4CKDM5BKDM5CKDM6BKDM4A
SCHEMBL19664325 0.69 KDM5B (0.44) KDM4CKDM5BKDM5CKDM6BKDM4A
SCHEMBL16291524 0.69 KDM5B (0.44) KDM4CKDM5BKDM5CKDM6BKDM4A
SCHEMBL17144521 0.69 KDM5B (0.45) KDM4CKDM5BKDM5CKDM6BKDM4A
SCHEMBL19574371 0.68 KDM5B (0.45) KDM4CKDM5BKDM5CKDM6BKDM4A
SCHEMBL19549130 0.68 KDM5B (0.47) KDM4CKDM5BKDM5CKDM6BKDM4A
SCHEMBL17144516 0.67 ALDH1A1 (0.39) KDM5BKDM5CKDM6BKDM4AKDM5A
SCHEMBL16291806 0.67 KDM5B (0.53) KDM4CKDM5BKDM5CKDM6BKDM4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170369444-A1 INHIBITORS OF HISTONE DEMETHYLASES EPITHERAPEUTICS APS (DK) 2017-12-28 — — US claimed
US-20170369444-A1 INHIBITORS OF HISTONE DEMETHYLASES EPITHERAPEUTICS APS (DK) 2017-12-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170369444-A1 INHIBITORS OF HISTONE DEMETHYLASES KDM1B, KDM3A, KDM1A KDM4C 38/4885HPGD 717/4885KDM5B 33/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback